Reply: Intravenous glutathione in Parkinson's disease
Identifieur interne : 002429 ( Istex/Corpus ); précédent : 002428; suivant : 002430Reply: Intravenous glutathione in Parkinson's disease
Auteurs : Robert A. Hauser ; Kelly E. LyonsSource :
- Movement Disorders [ 0885-3185 ] ; 2010-05-15.
Url:
DOI: 10.1002/mds.23028
Links to Exploration step
ISTEX:D1E1398F25DDF0EAFCF25EA72BD568B40243AA4BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reply: Intravenous glutathione in Parkinson's disease</title>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
<affiliation><mods:affiliation>Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Lyons, Kelly E" sort="Lyons, Kelly E" uniqKey="Lyons K" first="Kelly E." last="Lyons">Kelly E. Lyons</name>
<affiliation><mods:affiliation>Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D1E1398F25DDF0EAFCF25EA72BD568B40243AA4B</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.23028</idno>
<idno type="url">https://api.istex.fr/document/D1E1398F25DDF0EAFCF25EA72BD568B40243AA4B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002429</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Reply: Intravenous glutathione in Parkinson's disease</title>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
<affiliation><mods:affiliation>Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Lyons, Kelly E" sort="Lyons, Kelly E" uniqKey="Lyons K" first="Kelly E." last="Lyons">Kelly E. Lyons</name>
<affiliation><mods:affiliation>Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-05-15">2010-05-15</date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="962">962</biblScope>
<biblScope unit="page" to="963">963</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">D1E1398F25DDF0EAFCF25EA72BD568B40243AA4B</idno>
<idno type="DOI">10.1002/mds.23028</idno>
<idno type="ArticleID">MDS23028</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<istex><corpusName>wiley</corpusName>
<author><json:item><name>Robert A. Hauser MD</name>
<affiliations><json:string>Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA</json:string>
</affiliations>
</json:item>
<json:item><name>Kelly E. Lyons PhD</name>
<affiliations><json:string>Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA</json:string>
</affiliations>
</json:item>
</author>
<genre><json:string>Serial article</json:string>
</genre>
<host><volume>25</volume>
<pages><total>2</total>
<last>963</last>
<first>962</first>
</pages>
<issn><json:string>0885-3185</json:string>
</issn>
<issue>7</issue>
<subject><json:item><value>Letter to the Editor</value>
</json:item>
</subject>
<genre></genre>
<language><json:string>unknown</json:string>
</language>
<title>Movement Disorders</title>
<doi><json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<language><json:string>eng</json:string>
</language>
<qualityIndicators><score>5.05</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>612 x 810 pts</pdfPageSize>
<refBibsNative>false</refBibsNative>
<abstractCharCount>0</abstractCharCount>
<pdfWordCount>5016</pdfWordCount>
<pdfCharCount>33248</pdfCharCount>
<pdfPageCount>8</pdfPageCount>
<abstractWordCount>0</abstractWordCount>
</qualityIndicators>
<title>Reply: Intravenous glutathione in Parkinson's disease</title>
<publicationDate>2010</publicationDate>
<copyrightDate>2010</copyrightDate>
<doi><json:string>10.1002/mds.23028</json:string>
</doi>
<id>D1E1398F25DDF0EAFCF25EA72BD568B40243AA4B</id>
<fulltext><json:item><original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/D1E1398F25DDF0EAFCF25EA72BD568B40243AA4B/fulltext/pdf</uri>
</json:item>
<json:item><original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/D1E1398F25DDF0EAFCF25EA72BD568B40243AA4B/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/D1E1398F25DDF0EAFCF25EA72BD568B40243AA4B/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Reply: Intravenous glutathione in Parkinson's disease</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability><p>Wiley Subscription Services, Inc., A Wiley Company</p>
</availability>
<date>2010</date>
</publicationStmt>
<notesStmt><note type="content">*Potential conflict of interest: The authors indicate that they have no relevant financial conflicts.</note>
</notesStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Reply: Intravenous glutathione in Parkinson's disease</title>
<author><persName><forename type="first">Robert A.</forename>
<surname>Hauser</surname>
<roleName type="degree">MD</roleName>
</persName>
<note type="correspondence"><p>Correspondence: Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA</p>
</note>
<affiliation>Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA</affiliation>
</author>
<author><persName><forename type="first">Kelly E.</forename>
<surname>Lyons</surname>
<roleName type="degree">PhD</roleName>
</persName>
<affiliation>Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA</affiliation>
</author>
</analytic>
<monogr><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-05-15"></date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="962">962</biblScope>
<biblScope unit="page" to="963">963</biblScope>
</imprint>
</monogr>
<idno type="istex">D1E1398F25DDF0EAFCF25EA72BD568B40243AA4B</idno>
<idno type="DOI">10.1002/mds.23028</idno>
<idno type="ArticleID">MDS23028</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>2010</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<textClass><keywords scheme="Journal Subject"><list><head>Article category</head>
<item><term>Letter to the Editor</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc><change when="2010-05-15">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/D1E1398F25DDF0EAFCF25EA72BD568B40243AA4B/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup><id type="product" value="MDS"></id>
</idGroup>
<titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="70"><doi origin="wiley" registered="yes">10.1002/mds.v25:7</doi>
<numberingGroup><numbering type="journalVolume" number="25">25</numbering>
<numbering type="journalIssue">7</numbering>
</numberingGroup>
<coverDate startDate="2010-05-15">15 May 2010</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="letter" position="320" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.23028</doi>
<idGroup><id type="unit" value="MDS23028"></id>
</idGroup>
<countGroup><count type="pageTotal" number="2"></count>
</countGroup>
<titleGroup><title type="articleCategory">Letter to the Editor</title>
<title type="tocHeading1">Letters to the Editor Related to Published Articles</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 2010 Movement Disorder Society</copyright>
<eventGroup><event type="firstOnline" date="2010-04-13"></event>
<event type="publishedOnlineFinalForm" date="2010-05-05"></event>
<event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2010-04-13"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.5.2 mode:FullText" date="2011-08-12"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst">962</numbering>
<numbering type="pageLast">963</numbering>
</numberingGroup>
<correspondenceTo>Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA</correspondenceTo>
<linkGroup><link type="toTypesetVersion" href="file:MDS.MDS23028.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="figureTotal" number="0"></count>
<count type="tableTotal" number="0"></count>
<count type="referenceTotal" number="6"></count>
<count type="wordTotal" number="804"></count>
</countGroup>
<titleGroup><title type="main" xml:lang="en">Reply: Intravenous glutathione in Parkinson's disease<link href="#fn1"></link>
</title>
</titleGroup>
<creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Robert A.</givenNames>
<familyName>Hauser</familyName>
<degrees>MD</degrees>
</personName>
<contactDetails><email>rhauser@hsc.usf.edu</email>
</contactDetails>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Kelly E.</givenNames>
<familyName>Lyons</familyName>
<degrees>PhD</degrees>
</personName>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="US" type="organization"><unparsedAffiliation>Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af4" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA</unparsedAffiliation>
</affiliation>
</affiliationGroup>
</contentMeta>
<noteGroup><note xml:id="fn1"><p>Potential conflict of interest: The authors indicate that they have no relevant financial conflicts.</p>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<!--Version 0.6 générée le 3-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Reply: Intravenous glutathione in Parkinson's disease</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>Reply: Intravenous glutathione in Parkinson's disease</title>
</titleInfo>
<name type="personal"><namePart type="given">Robert A.</namePart>
<namePart type="family">Hauser</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA</affiliation>
<description>Correspondence: Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA</description>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Kelly E.</namePart>
<namePart type="family">Lyons</namePart>
<namePart type="termsOfAddress">PhD</namePart>
<affiliation>Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="originalCategForm">letter</genre>
<originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place><placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2010-05-15</dateIssued>
<copyrightDate encoding="w3cdtf">2010</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
<extent unit="references">6</extent>
<extent unit="words">804</extent>
</physicalDescription>
<note type="content">*Potential conflict of interest: The authors indicate that they have no relevant financial conflicts.</note>
<relatedItem type="host"><titleInfo><title>Movement Disorders</title>
</titleInfo>
<titleInfo type="abbreviated"><title>Mov. Disord.</title>
</titleInfo>
<subject><genre>article category</genre>
<topic>Letter to the Editor</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part><date>2010</date>
<detail type="volume"><caption>vol.</caption>
<number>25</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>7</number>
</detail>
<extent unit="pages"><start>962</start>
<end>963</end>
<total>2</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">D1E1398F25DDF0EAFCF25EA72BD568B40243AA4B</identifier>
<identifier type="DOI">10.1002/mds.23028</identifier>
<identifier type="ArticleID">MDS23028</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2010 Movement Disorder Society</accessCondition>
<recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
<recordContentSource>WILEY</recordContentSource>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002429 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002429 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:D1E1398F25DDF0EAFCF25EA72BD568B40243AA4B |texte= Reply: Intravenous glutathione in Parkinson's disease }}
This area was generated with Dilib version V0.6.23. |